Organization
Molecular Immunology Unit
2 abstracts
Abstract
Updated results and subgroup analysis by presence of liver metastases of a phase I/II study of the EP4 antagonist vorbipiprant with the anti-PD-1 balstilimab in mismatch-repair-proficient and microsatellite stable (pMMR/MSS) chemorefractory metastatic colorectal cancer (mCRC).Org: Monza, Italy, Rottapharm Biotech and University of Milan - Bicocca, Molecular Immunology Unit, Experimental Oncology Department,
Abstract
Effect of SNPs in TMPRSS2 to severe COVID-19 in patients with prostate cancer.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Molecular Immunology Unit, Department of Experimental Oncology, Programma Prostata,